FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hertzel Gerstein

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Anatomy

Insulin-Secreting Cells

Co-author Network

Publications

TOP 3
Hertzel C Gerstein; Faramarz Ismail-Beigi; Ulrich Schubart; Walter T Ambrosius; Maryann Banerji; Jorge Calles; Emily Y Chew; William Cushman; Ronald Danis
Diabetic Retinopathy, Its Progression, and Incident Cardiovascular Events in the ACCORD Trial.
Johannes F E Mann; Lars Rydén; Peter Sleight; Koon K Teo; Salim Yusuf; Craig Anderson; Michael Boehm; Peggy Gao; Hertzel C Gerstein
Dual inhibition of the renin-angiotensin system in high-risk diabetes and risk for stroke and other outcomes: results of the ONTARGET trial.
Stewart B Harris; John Stewart; Lori Berard; Hertzel C Gerstein; Susan Webster-Bogaert; Jean-François Yale; Jordan W Tompkins
Can community retail pharmacist and diabetes expert support facilitate insulin initiation by family physicians? Results of the AIM@GP randomized controlled trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hertzel Gerstein (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Hertzel C Gerstein; Faramarz Ismail-Beigi; Ulrich Schubart; Walter T Ambrosius; Maryann Banerji; Jorge Calles; Emily Y Chew; William Cushman; Ronald Danis
Diabetic Retinopathy, Its Progression, and Incident Cardiovascular Events in the ACCORD Trial.
Diabetes care 2013;36(5):1266-71.
2013: Johannes F E Mann; Lars Rydén; Peter Sleight; Koon K Teo; Salim Yusuf; Craig Anderson; Michael Boehm; Peggy Gao; Hertzel C Gerstein
Dual inhibition of the renin-angiotensin system in high-risk diabetes and risk for stroke and other outcomes: results of the ONTARGET trial.
Journal of hypertension 2013;31(2):414-21.
2013: Stewart B Harris; John Stewart; Lori Berard; Hertzel C Gerstein; Susan Webster-Bogaert; Jean-François Yale; Jordan W Tompkins
Can community retail pharmacist and diabetes expert support facilitate insulin initiation by family physicians? Results of the AIM@GP randomized controlled trial.
BMC health services research 2013;13():71.
2012: Jennifer E Bruin; Hertzel C Gerstein; Bart P Hettinga; Katherine Morrison; Mark A Tarnopolsky; Amanda K Woynillowicz; Alison C Holloway
Maternal antioxidants prevent β-cell apoptosis and promote formation of dual hormone-expressing endocrine cells in male offspring following fetal and neonatal nicotine exposure.
Journal of diabetes 2012;4(3):297-306.
2012: Jackie Bosch; Gilles R Dagenais; Rafael Díaz; Hertzel C Gerstein; Hyejung Jung; Aldo P Maggioni; Janice Pogue; Jeffrey Probstfield; Ambady Ramachandran; Matthew C Riddle; Lars E Rydén; Salim Yusuf
Basal insulin and cardiovascular and other outcomes in dysglycemia.
The New England journal of medicine 2012;367(4):319-28.
2012: Jackie Bosch; Gilles R Dagenais; Rafael Díaz; Leanne Dyal; Hertzel C Gerstein; Hyejung Jung; Aldo P Maggiono; Jeffrey Probstfield; Ambady Ramachandran; Matthew C Riddle; Lars E Rydén; Salim Yusuf
n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.
The New England journal of medicine 2012;367(4):309-18.
2012: Natalia Yakubovich; Hertzel C Gerstein
Is regression to normoglycaemia clinically important?
Lancet 2012;379(9833):2216-8.
2012: Zubin Punthakee; Elizabeth R Seaquist; Mark D Sullivan; Jeff D Williamson; Richard M Bergenstal; Tali Cukierman-Yaffee; Hertzel C Gerstein; Faramarz Ismail-Beigi; Lenore J Launer; Ronald M Lazar; Laura C Lovato; Michael E Miller
Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial.
Diabetes care 2012;35(4):787-93.
2012: Ambady Ramachandran; Matthew C Riddle; Hertzel C Gerstein; Conrad Kabali
Relationship between A1C and fasting plasma glucose in dysglycemia or type 2 diabetes: an analysis of baseline data from the ORIGIN trial.
Diabetes care 2012;35(4):749-53.
2012: Madhu K Natarajan; Michael Rokoss; Peter Seidelin; Tej N Sheth; Bradley H Strauss; Changchun Xie; Christopher E Buller; Eric A Cohen; David Goodhart; William Harper; G B John Mancini; Hertzel C Gerstein
Randomized trial of insulin versus usual care in reducing restenosis after coronary intervention in patients with diabetes. the STent Restenosis And Metabolism (STREAM) study.
Cardiovascular revascularization medicine : including molecular interventions 2012;13(2):95-100.
2012: Faramarz Ismail-Beigi; Diane Karl; Lois Katz; Patrick J O'Connor; Jeffrey L Probstfield; Ulrich Schubart; Jorge Calles-Escandon; Timothy E Craven; William C Cushman; Saul Genuth; Hertzel C Gerstein; Irene Hramiak
Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients.
Kidney international 2012;81(6):586-94.
2012: Pavel S Roshanov; Rolf J Sebaldt; Hertzel C Gerstein; Dereck L Hunt; R Brian Haynes
Impact of a computerized system for evidence-based diabetes care on completeness of records: a before-after study.
BMC medical informatics and decision making 2012;12():63.
2012: Kara A Nerenberg; Jennifer Ng; Alben Sigamani; Denis Xavier; Salim Yusuf; Rafael Díaz; Hertzel C Gerstein; Abhinav Goyal; Mikhail Kosiborod; Shamir R Mehta
Piloting a novel algorithm for glucose control in the coronary care unit: the RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) trial.
Diabetes care 2012;35(1):19-24.
2011: Lenore J Launer; Ron M Lazar; Edward W Lipkin; James Lovato; Laura C Lovato; Joseph Maldjian; Santica Marcovina; Karen L Margolis; Michael E Miller; Anne M Murray; Patrick O'Connor; Mark Sullivan; Jeffrey L Sunshine; Charles Truwit; Jeff D Williamson; R Nick Bryan; Laura H Coker; Christos Davatzikos; Jingzhong Ding; Hertzel C Gerstein; Joy Hirsch; Karen R Horowitz
Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy.
Lancet neurology 2011;10(11):969-77.
2011: Sheena Kayaniyil; Julia A Knight; Bruce A Perkins; Ravi Retnakaran; Reinhold Vieth; Bernard Zinman; Hertzel C Gerstein; Stewart B Harris; Anthony J Hanley
Prospective associations of vitamin D with β-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study.
Diabetes 2011;60(11):2947-53.
2011: Erik A Badings; Lyanne Dyal; Martin N Gerding; Hertzel C Gerstein; Dirk J A Lok; Lydia Schoterman; Ies Stoel; Jan G P Tijssen
Strategies to detect abnormal glucose metabolism in people at high risk of cardiovascular disease from the ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial population.
Journal of diabetes 2011;3(3):232-7.
2011: Diana Sherifali; Gaya Amirthavasar; Sarah Capes; Ron Goeree; Janet L Greb; William Harper; R Brian Haynes; Anne Holbrook; Dereck Hunt; Daria O'Reilly; Eleanor Pullenayegum; Hertzel C Gerstein
Effect of computer-generated tailored feedback on glycemic control in people with diabetes in the community: a randomized controlled trial.
Diabetes care 2011;34(8):1794-8.
2011: Hertzel C Gerstein; Michael E Miller; Saul Genuth; Faramarz Ismail-Beigi; John B Buse; David C Goff; Jeffrey L Probstfield; William C Cushman; Henry N Ginsberg; J Thomas Bigger; Richard H Grimm; Robert P Byington; Yves D Rosenberg; William T Friedewald
Long-term effects of intensive glucose lowering on cardiovascular outcomes.
The New England journal of medicine 2011;364(9):818-28.
2011: Catherine M McGorrian; Salim Yusuf; Shofiqul Islam; Hyejung Jung; Sumathy Rangarajan; Alvaro Avezum; Dorairaj Prabhakaran; Wael Almahmeed; Zvonko Rumboldt; Andrzej Budaj; Antonio L Dans; Hertzel C Gerstein; Koon Teo; Sonia S Anand
Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score.
European heart journal 2011;32(5):581-9.
2011: Alison C Holloway; Bart P Hettinga; Hertzel C Gerstein
Effect of combining rosiglitazone with either metformin or insulin on β-cell mass and function in an animal model of Type 2 diabetes characterized by reduced β-cell mass at birth.
Journal of diabetes 2011;3(1):74-81.
2011: Hertzel C Gerstein
Dysglycaemia, dyslipidaemia and hypertension: risk factors primarily focused on the disease or risk estimates primarily focused on the patient?
Diabetologia 2011;54(2):230-2.
2011: Natalia Yakubovich; Hertzel C Gerstein
Serious cardiovascular outcomes in diabetes: the role of hypoglycemia.
Circulation 2011;123(3):342-8.
2011: Sonia S Anand; Dipika Desai; Hertzel C Gerstein; Andrew Mente; Sandy Rao; Shirya Rashid; Karleen M Schulze; Mark A Tarnopolsky; Salim Yusuf; Arya M Sharma
Adipocyte hypertrophy, fatty liver and metabolic risk factors in South Asians: the Molecular Study of Health and Risk in Ethnic Groups (mol-SHARE).
PloS one 2011;6(7):e22112.
2011: Sheena Kayaniyil; Reinhold Vieth; Stewart B Harris; Ravi Retnakaran; Julia A Knight; Hertzel C Gerstein; Bruce A Perkins; Bernard Zinman; Anthony J Hanley
Association of 25(OH)D and PTH with metabolic syndrome and its traditional and nontraditional components.
The Journal of clinical endocrinology and metabolism 2011;96(1):168-75.
2010: Swneke D Bailey; Changchun Xie; Ron Do; Alexandre Montpetit; Rafael Diaz; Viswanathan Mohan; Bernard Keavney; Salim Yusuf; Hertzel C Gerstein; James C Engert; Sonia Anand
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Diabetes care 2010;33(10):2250-3.
2010: Diana Sherifali; Kara Nerenberg; Eleanor Pullenayegum; Ji Emmy Cheng; Hertzel C Gerstein
The effect of oral antidiabetic agents on A1C levels: a systematic review and meta-analysis.
Diabetes care 2010;33(8):1859-64.
2010: Jennifer E Bruin; Hertzel C Gerstein; Alison C Holloway
Long-term consequences of fetal and neonatal nicotine exposure: a critical review.
Toxicological sciences : an official journal of the Society of Toxicology 2010;116(2):364-74.
2010: Emily Y Chew; Walter T Ambrosius; Matthew D Davis; Ronald P Danis; Sapna Gangaputra; Craig M Greven; Larry Hubbard; Barbara A Esser; James F Lovato; Letitia H Perdue; David C Goff; William C Cushman; Henry N Ginsberg; Marshall B Elam; Saul Genuth; Hertzel C Gerstein; Ulrich Schubart; Lawrence Fine
Effects of medical therapies on retinopathy progression in type 2 diabetes.
The New England journal of medicine 2010;363(3):233-44.
2010: Bernard Zinman; Stewart B Harris; Jan Neuman; Hertzel C Gerstein; Ravi R Retnakaran; Janet Raboud; Ying Qi; Anthony J G Hanley
Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study.
Lancet 2010;376(9735):103-11.
2010: Hertzel C Gerstein; Salim Yusuf
Clinical outcomes trials and the cardiovascular effects of thiazolidinediones: implications for the evaluation of antidiabetic drugs.
American heart journal 2010;160(1):1-2.
2010: L de Koning; Hertzel C Gerstein; Jackie Bosch; Rafael Diaz; V Mohan; Gilles R Dagenais; Salim Yusuf; Sonia S Anand
Anthropometric measures and glucose levels in a large multi-ethnic cohort of individuals at risk of developing type 2 diabetes.
Diabetologia 2010;53(7):1322-30.
2010: Rodica Pop-Busui; Gregory W Evans; Hertzel C Gerstein; Vivian Fonseca; Jerome L Fleg; Byron J Hoogwerf; Saul Genuth; Richard H Grimm; Marshall A Corson; Ronald Prineas
Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
Diabetes care 2010;33(7):1578-84.
2010: Hertzel C Gerstein
More insights on the dysglycaemia-cardiovascular connection.
Lancet 2010;375(9733):2195-6.
2010: Manoela Braga; Amparo Casanova; Hwee Teoh; Keith C Dawson; Hertzel C Gerstein; David H Fitchett; Stewart B Harris; George Honos; Philip A McFarlane; Andrew Steele; Ehud Ur; Jean-François Yale; Anatoly Langer; Shaun G Goodman; Lawrence A Leiter
Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada.
The Canadian journal of cardiology 2010;26(6):297-302.
2010: Sarah D McDonald; Zhen Han; Michael W Walsh; Hertzel C Gerstein; Philip J Devereaux
Kidney disease after preeclampsia: a systematic review and meta-analysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2010;55(6):1026-39.
2010: Eleanor M Pullenayegum; Jean-Eric Tarride; Feng Xie; Ron Goeree; Hertzel C Gerstein; Daria O'Reilly
Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate?
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2010;13(4):487-94.
2010: Sheena Kayaniyil; Reinhold Vieth; Ravi Retnakaran; Julia A Knight; Ying Qi; Hertzel C Gerstein; Bruce A Perkins; Stewart B Harris; Bernard Zinman; Anthony J Hanley
Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes.
Diabetes care 2010;33(6):1379-81.
2010: Sanne G Swinnen; Marie-Paule Dain; Ronnie Aronson; Melanie Davies; Hertzel C Gerstein; Andreas F Pfeiffer; Frank J Snoek; J Hans Devries; Joost B Hoekstra; Frits Holleman
A 24-week, randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs.
Diabetes care 2010;33(6):1176-8.
2010: Andrew Mente; Salim Yusuf; Shofiqul Islam; Matthew J McQueen; Supachai Tanomsup; Churchill L Onen; Sumathy Rangarajan; Hertzel C Gerstein; Sonia S Anand
Metabolic syndrome and risk of acute myocardial infarction a case-control study of 26,903 subjects from 52 countries.
Journal of the American College of Cardiology 2010;55(21):2390-8.
2010: Henry N Ginsberg; Marshall B Elam; Laura C Lovato; John R Crouse; Lawrence A Leiter; Peter Linz; William T Friedewald; John B Buse; Hertzel C Gerstein; Jeffrey Probstfield; Richard H Grimm; Faramarz Ismail-Beigi; J Thomas Bigger; David C Goff; William C Cushman; Denise G Simons-Morton; Robert P Byington
Effects of combination lipid therapy in type 2 diabetes mellitus.
The New England journal of medicine 2010;362(17):1563-74.
2010: William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Effects of intensive blood-pressure control in type 2 diabetes mellitus.
The New England journal of medicine 2010;362(17):1575-85.
2010: Jennifer E Bruin; James J Petrik; Jillian R Hyslop; Sandeep Raha; Mark A Tarnopolsky; Hertzel C Gerstein; Alison C Holloway
Rosiglitazone improves pancreatic mitochondrial function in an animal model of dysglycemia: role of the insulin-like growth factor axis.
Endocrine 2010;37(2):303-11.
2010: Hertzel C Gerstein; Robert E Ratner; Christopher P Cannon; Patrick Washington Serruys; Héctor M García-García; Gerrit-Anne van Es; Nikheel S Kolatkar; Barbara G Kravitz; Diane M Miller; Chun Huang; Peter J Fitzgerald; Richard W Nesto
Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial.
Circulation 2010;121(10):1176-87.
2010: Walter T Ambrosius; Ronald P Danis; David C Goff; Craig M Greven; Hertzel C Gerstein; Robert M Cohen; Matthew C Riddle; Michael E Miller; John B Buse; Denise E Bonds; Kevin A Peterson; Yves D Rosenberg; Letitia H Perdue; Barbara A Esser; Lea A Seaquist; James V Felicetta; Emily Y Chew
Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudy.
Archives of ophthalmology 2010;128(3):312-8.
2010: Anthony J Hanley; Bernard Zinman; Patrick Sheridan; Salim Yusuf; Hertzel C Gerstein
Effect of Rosiglitazone and Ramipril on {beta}-cell function in people with impaired glucose tolerance or impaired fasting glucose: the DREAM trial.
Diabetes care 2010;33(3):608-13.
2010: Hertzel C Gerstein
Does insulin therapy promote, reduce, or have a neutral effect on cancers?
JAMA : the journal of the American Medical Association 2010;303(5):446-7.
2010: Michael E Miller; Denise E Bonds; Hertzel C Gerstein; Elizabeth R Seaquist; Richard M Bergenstal; Jorge Calles-Escandon; R Dale Childress; Timothy E Craven; Robert M Cuddihy; George Dailey; Mark N Feinglos; Farmarz Ismail-Beigi; Joe F Largay; Patrick J O'Connor; Terri Paul; Peter J Savage; Ulrich Schubart; Ajay Sood; Saul Genuth
The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.
BMJ (Clinical research ed.) 2010;340():b5444.
2009: Abhinav Goyal; Shamir R Mehta; Rafael Díaz; Hertzel C Gerstein; Rizwan Afzal; Denis Xavier; Lisheng Liu; Prem Pais; Salim Yusuf
Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction.
Circulation 2009;120(24):2429-37.
2009: Anthony J G Hanley; Ravi Retnakaran; Ying Qi; Hertzel C Gerstein; Bruce Perkins; Janet Raboud; Stewart B Harris; Bernard Zinman
Association of hematological parameters with insulin resistance and beta-cell dysfunction in nondiabetic subjects.
The Journal of clinical endocrinology and metabolism 2009;94(10):3824-32.
2009: Colette E Jackson; Scott D Solomon; Hertzel C Gerstein; Sofia Zetterstrand; Bertil Olofsson; Eric L Michelson; Christopher B Granger; Karl Swedberg; Marc A Pfeffer; Salim Yusuf; John J V McMurray
Albuminuria in chronic heart failure: prevalence and prognostic importance.
Lancet 2009;374(9689):543-50.
2009: Anne Holbrook; Lehana Thabane; Karim Keshavjee; Lisa Dolovich; Bob Bernstein; David Chan; Sue Troyan; Gary Foster; Hertzel C Gerstein
Individualized electronic decision support and reminders to improve diabetes care in the community: COMPETE II randomized trial.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2009;181(1-2):37-44.
2009: Eva Lonn; Hertzel C Gerstein; Patrick Sheridan; Sandra Smith; Rafael Diaz; Viswanathan Mohan; Jackie Bosch; Salim Yusuf; Gilles R Dagenais
Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone).
Journal of the American College of Cardiology 2009;53(22):2028-35.
2009: Hertzel C Gerstein
Is it possible to reduce cardiovascular risk with glucose-lowering approaches?
Nature reviews. Endocrinology 2009;5(5):270-5.
2009: David Preiss; Sofia Zetterstrand; John J V McMurray; Jan Ostergren; Eric L Michelson; Christopher B Granger; Salim Yusuf; Karl Swedberg; Marc A Pfeffer; Hertzel C Gerstein; Naveed Sattar
Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program.
Diabetes care 2009;32(5):915-20.
2009: Abhinav Goyal; Shamir R Mehta; Hertzel C Gerstein; Rafael Díaz; Rizwan Afzal; Denis Xavier; Jun Zhu; Prem Pais; Liu Lisheng; Khawar A Kazmi; Mohammad Zubaid; Leopoldo S Piegas; Petr Widimsky; Andrzej Budaj; Alvaro Avezum; Salim Yusuf
Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction.
American heart journal 2009;157(4):763-70.
2009: Tali Cukierman-Yaffe; Hertzel C Gerstein; Craig Anderson; Feng Zhao; Peter Sleight; Lutz Hilbrich; Stephen H D Jackson; Salim Yusuf; Koon Teo
Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme.
Diabetes research and clinical practice 2009;83(3):387-93.
2009: Hertzel C Gerstein
Dysglycemia and cardiovascular risk in the general population.
Circulation 2009;119(6):773-5.
2009: Tali Cukierman-Yaffe; Hertzel C Gerstein; Jeff D Williamson; Ronald M Lazar; Laura Lovato; Michael E Miller; Laura H Coker; Anne Murray; Mark D Sullivan; Santica M Marcovina; Lenore J Launer
Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial.
Diabetes care 2009;32(2):221-6.
2008: Robert E Ratner; Christopher P Cannon; Hertzel C Gerstein; Richard W Nesto; Patrick Washington Serruys; Gerrit-Anne van Es; Nikheel S Kolatkar; Barbara G Kravitz; Andrew Zalewski; Peter J Fitzgerald
Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in diabetes patients with Cardiovascular History (APPROACH): study design and baseline characteristics.
American heart journal 2008;156(6):1074-9.
2008: Abhinav Goyal; Kara Nerenberg; Hertzel C Gerstein; Guillermo Umpierrez; Peter W F Wilson
Insulin therapy in acute coronary syndromes: an appraisal of completed and ongoing randomised trials with important clinical end points.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2008;5(4):276-84.
2008: Alison C Holloway; J J Petrik; J E Bruin; Hertzel C Gerstein
Rosiglitazone prevents diabetes by increasing beta-cell mass in an animal model of type 2 diabetes characterized by reduced beta-cell mass at birth.
Diabetes, obesity & metabolism 2008;10(9):763-71.
2008: Gianluca Iacobellis; Giuseppe Barbaro; Hertzel C Gerstein
Relationship of epicardial fat thickness and fasting glucose.
International journal of cardiology 2008;128(3):424-6.
2008: Hertzel C Gerstein; Karl Swedberg; Jonas Carlsson; John J V McMurray; Eric L Michelson; Bertil Olofsson; Marc A Pfeffer; Salim Yusuf
The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program.
Archives of internal medicine 2008;168(15):1699-704.
2008: Sarah D McDonald; Salim Yusuf; Patrick Sheridan; Sonia S Anand; Hertzel C Gerstein
Dysglycemia and a history of reproductive risk factors.
Diabetes care 2008;31(8):1635-8.
2008: Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise Simons-Morton; William T Friedewald
Effects of intensive glucose lowering in type 2 diabetes.
The New England journal of medicine 2008;358(24):2545-59.
2008: Jennifer E Bruin; Maria A Petre; Megan A Lehman; Sandeep Raha; Hertzel C Gerstein; Katherine Morrison; Alison C Holloway
Maternal nicotine exposure increases oxidative stress in the offspring.
Free radical biology & medicine 2008;44(11):1919-25.
2008: Jennifer E Bruin; Hertzel C Gerstein; Katherine Morrison; Alison C Holloway
Increased pancreatic beta-cell apoptosis following fetal and neonatal exposure to nicotine is mediated via the mitochondria.
Toxicological sciences : an official journal of the Society of Toxicology 2008;103(2):362-70.
2008: Jennifer E Bruin; Maria A Petre; Sandeep Raha; Katherine Morrison; Hertzel C Gerstein; Alison C Holloway
Fetal and neonatal nicotine exposure in Wistar rats causes progressive pancreatic mitochondrial damage and beta cell dysfunction.
PloS one 2008;3(10):e3371.
2007: Neville Suskin; George Heigenhauser; Rizwan Afzal; Diane Finegood; Hertzel C Gerstein; Robert S McKelvie
The effects of exercise training on insulin resistance in patients with coronary artery disease.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2007;14(6):803-8.
2007: Hertzel C Gerstein; Salim Yusuf
Does treatment with rosiglitazone increase cardiovascular risk of patients with type 2 diabetes mellitus?
Nature clinical practice. Endocrinology & metabolism 2007;3(12):798-9.
2007: Hertzel C Gerstein; P Lina Santaguida; Parminder Raina; Katherine Morrison; Cynthia Balion; Dereck Hunt; Hossein Yazdi; Lynda Booker
Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies.
Diabetes research and clinical practice 2007;78(3):305-12.
2007: Taryn Becker; Andrei Moldoveanu; Tali Cukierman; Hertzel C Gerstein
Clinical outcomes associated with the use of subcutaneous insulin-by-glucose sliding scales to manage hyperglycemia in hospitalized patients with pneumonia.
Diabetes research and clinical practice 2007;78(3):392-7.
2007: Lakshmi P Voruganti; Zubin Punthakee; R J Van Lieshout; D MacCrimmon; G Parker; A George Awad; Hertzel C Gerstein
Dysglycemia in a community sample of people treated for schizophrenia: the Diabetes in Schizophrenia in Central-South Ontario (DiSCO) study.
Schizophrenia research 2007;96(1-3):215-22.
2007: Robyn Houlden; Stuart Ross; Stewart Harris; Jean-François Yale; Luc Sauriol; Hertzel C Gerstein
Treatment satisfaction and quality of life using an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of Type 2 diabetes: the Canadian INSIGHT Study.
Diabetes research and clinical practice 2007;78(2):254-8.
2007: Jennifer E Bruin; Lisa D Kellenberger; Hertzel C Gerstein; Katherine Morrison; Alison C Holloway
Fetal and neonatal nicotine exposure and postnatal glucose homeostasis: identifying critical windows of exposure.
The Journal of endocrinology 2007;194(1):171-8.
2007: David C Goff; Hertzel C Gerstein; Henry N Ginsberg; William Cushman; Karen L Margolis; Robert P Byington; John B Buse; Saul Genuth; Jeffrey L Probstfield; Denise Simons-Morton
Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
The American journal of cardiology 2007;99(12A):4i-20i.
2007: Hertzel C Gerstein; Matthew C Riddle; David M Kendall; Robert M Cohen; Robin Goland; Mark N Feinglos; Julienne K Kirk; Bruce P Hamilton; Faramarz Ismail-Beigi; Patricia Feeney
Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
The American journal of cardiology 2007;99(12A):34i-43i.
2007: John B Buse; J Thomas Bigger; Robert P Byington; Lawton S Cooper; William Cushman; William T Friedewald; Saul Genuth; Hertzel C Gerstein; Henry N Ginsberg; David C Goff; Richard H Grimm; Karen L Margolis; Jeffrey L Probstfield; Denise Simons-Morton; Mark D Sullivan
Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.
The American journal of cardiology 2007;99(12A):21i-33i.
2007: Alison C Holloway; Donald Q Cuu; Katherine Morrison; Hertzel C Gerstein; Mark A Tarnopolsky
Transgenerational effects of fetal and neonatal exposure to nicotine.
Endocrine 2007;31(3):254-9.
2007: Claes Held; Hertzel C Gerstein; Salim Yusuf; F Zhao; Lutz Hilbrich; C Anderson; Peter Sleight; Koon Teo
Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk.
Circulation 2007;115(11):1371-5.
2007: Hertzel C Gerstein
Point: If it is important to prevent type 2 diabetes, it is important to consider all proven therapies within a comprehensive approach.
Diabetes care 2007;30(2):432-4.
2007: Azim S Gangji; Tali Cukierman; Hertzel C Gerstein; Charles H Goldsmith; Catherine M Clase
A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin.
Diabetes care 2007;30(2):389-94.
2007: John B Buse; Henry N Ginsberg; George L Bakris; Nathaniel G Clark; Fernando Costa; Robert Eckel; Vivian Fonseca; Hertzel C Gerstein; Scott Grundy; Richard W Nesto; Michael Pignone; Jorge Plutzky; Daniel Porte; Rita F Redberg; Kimberly F Stitzel; Neil stone
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
Circulation 2007;115(1):114-26.
2007: Kalpana M Nair; Mitchel A H Levine; Lynne H Lohfeld; Hertzel C Gerstein
"I take what I think works for me": a qualitative study to explore patient perception of diabetes treatment benefits and risks.
The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 2007;14(2):e251-9.
2007: Zubin Punthakee; Geoff Werstuck; Hertzel C Gerstein
Diabetes and cardiovascular disease: explaining the relationship.
Reviews in cardiovascular medicine 2007;8(3):145-53.
2007: Cynthia Balion; Parminder Raina; Hertzel C Gerstein; P Lina Santaguida; Katherine Morrison; Lynda Booker; Dereck L Hunt
Reproducibility of impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) classification: a systematic review.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2007;45(9):1180-5.
2007: John B Buse; Henry N Ginsberg; George L Bakris; Nathaniel G Clark; Fernando Costa; Robert Eckel; Vivian Fonseca; Hertzel C Gerstein; Scott Grundy; Richard W Nesto; Michael Pignone; Jorge Plutzky; Daniel Porte; Rita F Redberg; Kimberly F Stitzel; Neil stone
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
Diabetes care 2007;30(1):162-72.
2006: Matthew J McQueen; Hertzel C Gerstein; Janice Pogue; Johannes F E Mann; Salim Yusuf
Reevaluation by high-performance liquid chromatography: clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2006;48(6):889-96.
2006: Jackie Bosch; Salim Yusuf; Hertzel C Gerstein; Janice Pogue; Patrick Sheridan; Gilles R Dagenais; Rafael Diaz; Alvaro Avezum; Fernando Lanas; Jeffrey L Probstfield; George Fodor; Rury R Holman
Effect of ramipril on the incidence of diabetes.
The New England journal of medicine 2006;355(15):1551-62.
2006: Hertzel C Gerstein; Salim Yusuf; J Bosch; Janice Pogue; Patrick Sheridan; N Dinccag; M Hanefeld; B Hoogwerf; M Laakso; V Mohan; J Shaw; B Zinman; R R Holman
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
Lancet 2006;368(9541):1096-105.
2006: Stefan Blankenberg; Matthew J McQueen; Marek Smieja; Janice Pogue; Cynthia Balion; Eva Lonn; Hans J Rupprecht; Christoph Bickel; Laurence Tiret; François Cambien; Hertzel C Gerstein; Thomas Münzel; Salim Yusuf
Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
Circulation 2006;114(3):201-8.
2006: Hertzel C Gerstein; Jean-François Yale; S B Harris; M Issa; J A Stewart; E Dempsey
A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study.
Diabetic medicine : a journal of the British Diabetic Association 2006;23(7):736-42.
2006: Hertzel C Gerstein
Intensive insulin therapy reduced cardiovascular disease in type 1 diabetes.
ACP journal club 2006;144(3):63.
2006: Rajesh Hiralal; Karen K Y Koo; Hertzel C Gerstein
Does pioglitazone prevent macrovascular events in patients with type 2 diabetes?
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2006;174(8):1090-1.
2006: Hertzel C Gerstein; Laura Waltman
Why don't pigs get diabetes? Explanations for variations in diabetes susceptibility in human populations living in a diabetogenic environment.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2006;174(1):25-6.
2005: Tali Cukierman; Hertzel C Gerstein; Jeff D Williamson
Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies.
Diabetologia 2005;48(12):2460-9.
2005: Alison C Holloway; Gareth E Lim; James J Petrik; Warren G Foster; Katherine Morrison; Hertzel C Gerstein
Fetal and neonatal exposure to nicotine in Wistar rats results in increased beta cell apoptosis at birth and postnatal endocrine and metabolic changes associated with type 2 diabetes.
Diabetologia 2005;48(12):2661-6.
2005: Hertzel C Gerstein; Janice Pogue; Johannes F E Mann; Eva Lonn; Gilles R Dagenais; Matthew McQueen; Salim Yusuf
The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis.
Diabetologia 2005;48(9):1749-55.
2005: P Lina Santaguida; Cynthia Balion; D Hunt; K Morrison; Hertzel C Gerstein; Parminder Raina; Lynda Booker; H Yazdi
Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose.
Evidence report/technology assessment (Summary) 2005;(128):1-11.
2005: Salim Yusuf; Jan Ostergren; Hertzel C Gerstein; Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Bertil Olofsson; Jeffrey L Probstfield; John V McMurray
Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure.
Circulation 2005;112(1):48-53.
2005: Jay S Skyler; Ruth S Weinstock; Philip Raskin; Jean-François Yale; Eugene Barrett; John E Gerich; Hertzel C Gerstein
Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial.
Diabetes care 2005;28(7):1630-5.
2005: Johannes F E Mann; Qi-Long Yi; Peter Sleight; G R Dagenais; Hertzel C Gerstein; Eva Lonn; J Bosch
Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE study.
Clinical nephrology 2005;63(3):181-7.
2005: Hertzel C Gerstein; Julio Rosenstock
Insulin therapy in people who have dysglycemia and type 2 diabetes mellitus: can it offer both cardiovascular protection and beta-cell preservation?
Endocrinology and metabolism clinics of North America 2005;34(1):137-54.
2005: Denise Simons-Morton; Saul Genuth; Robert P Byington; Hertzel C Gerstein; William T Friedewald
The burden of treatment failure in type 2 diabetes: response to Brown et al.
Diabetes care 2005;28(3):761-2.
2005: Anne Holbrook; Karim Keshavjee; Hui Lee; Bob Bernstein; David Chan; Lehana Thabane; Hertzel C Gerstein; Sue Troyan
Individualized electronic decision support and reminders can improve diabetes care in the community.
AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium 2005;():982.
2005: Matthew J McQueen; Eva Lonn; Hertzel C Gerstein; J Bosch; Salim Yusuf
The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequences.
Scandinavian journal of clinical and laboratory investigation. Supplementum 2005;240():143-56.
2004: Andrew P Levy; Hertzel C Gerstein; Rachel Miller-Lotan; Robert Ratner; Matthew McQueen; Eva Lonn; Janice Pogue
The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.
Diabetes care 2004;27(11):2767.
2004: Hertzel C Gerstein; J Garon; C Joyce; A Rolfe; C M Walter
Pre-prandial vs. post-prandial capillary glucose measurements as targets for repaglinide dose titration in people with diet-treated or metformin-treated Type 2 diabetes: a randomized controlled clinical trial.
Diabetic medicine : a journal of the British Diabetic Association 2004;21(11):1200-3.
2004: Johannes F E Mann; Qi-Long Yi; Hertzel C Gerstein
Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease.
Kidney international. Supplement 2004;(92):S59-62.
2004: Hertzel C Gerstein
Glycosylated hemoglobin: finally ready for prime time as a cardiovascular risk factor.
Annals of internal medicine 2004;141(6):475-6.
2004: Anna M Sawka; Kullathorn Thephamongkhol; Melissa Brouwers; Lehana Thabane; George Browman; Hertzel C Gerstein
Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer.
The Journal of clinical endocrinology and metabolism 2004;89(8):3668-76.
2004: Dereck Hunt; Hertzel C Gerstein
Foot ulcers and amputations in diabetes.
Clinical evidence 2004;(11):743-52.
2004: Johannes F E Mann; Eva Lonn; Qilong Yi; Hertzel C Gerstein; Byron J Hoogwerf; Janice Pogue; Jackie Bosch; Gilles R Dagenais; Salim Yusuf
Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study.
Kidney international 2004;65(4):1375-80.
2003: Dereck Hunt; Hertzel C Gerstein
Foot ulcers and amputations in diabetes.
Clinical evidence 2003;(10):657-66.
2003: Hertzel C Gerstein
Enalapril reduced the risk for developing new-onset diabetes in left ventricular dysfunction.
ACP journal club 2003;139(3):68.
2003: Johannes F E Mann; Hertzel C Gerstein; Qi-Long Yi; Jörg Franke; Eva Lonn; Byron J Hoogwerf; Andrew Rashkow; Salim Yusuf
Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;42(5):936-42.
2003: Anna M Sawka; Hertzel C Gerstein; Michael Marriott; Glenda M MacQueen; Russell T Joffe
Does a combination regimen of thyroxine (T4) and 3,5,3'-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial.
The Journal of clinical endocrinology and metabolism 2003;88(10):4551-5.
2003: Sonia S Anand; Qilong Yi; Hertzel C Gerstein; Eva Lonn; Ruby Jacobs; Vladimir Vuksan; Koon Teo; Bonnie Davis; Patty Montague; Salim Yusuf
Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease.
Circulation 2003;108(4):420-5.
2003: Johannes F E Mann; Hertzel C Gerstein; Ioana Dulau-Florea; Eva Lonn
Cardiovascular risk in patients with mild renal insufficiency.
Kidney international. Supplement 2003;(84):S192-6.
2003: Johannes F E Mann; Hertzel C Gerstein; Qi-Long Yi; Eva Lonn; Byron J Hoogwerf; Andrew Rashkow; Salim Yusuf
Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study.
Journal of the American Society of Nephrology : JASN 2003;14(3):641-7.
2003: Sonia S Anand; Fahad Razak; Vladimir Vuksan; Hertzel C Gerstein; Klas Malmberg; Qilong Yi; Koon K Teo; Salim Yusuf
Diagnostic strategies to detect glucose intolerance in a multiethnic population.
Diabetes care 2003;26(2):290-6.
2003: Hertzel C Gerstein; Sonia Anand; Qi Long Yi; Vladimir Vuksan; Eva Lonn; Koon Teo; Klas Malmberg; Matthew McQueen; Salim Yusuf
The relationship between dysglycemia and atherosclerosis in South Asian, Chinese, and European individuals in Canada: a randomly sampled cross-sectional study.
Diabetes care 2003;26(1):144-9.
2002: Dereck Hunt; Hertzel C Gerstein
Foot ulcers and amputations in diabetes.
Clinical evidence 2002;(8):569-77.
2002: Eva Lonn; Salim Yusuf; Byron J Hoogwerf; Janice Pogue; Qilong Yi; Bernard Zinman; Jackie Bosch; Gilles R Dagenais; Johannes F E Mann; Hertzel C Gerstein
Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.
Diabetes care 2002;25(11):1919-27.
2002: Hertzel C Gerstein
Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE.
Diabetes/metabolism research and reviews 2002;18 Suppl 3():S82-5.
2002: Hertzel C Gerstein
Epidemiologic analyses of risk factors, risk indicators, risk markers, and causal factors. The example of albuminuria and the risk of cardiovascular disease in diabetes.
Endocrinology and metabolism clinics of North America 2002;31(3):537-51.
2002: Hertzel C Gerstein; Dereck Hunt
Foot ulcers and amputations in diabetes.
Clinical evidence 2002;(7):521-8.
2002: Hertzel C Gerstein; Sarah E Capes
Dysglycemia: a key cardiovascular risk factor.
Seminars in vascular medicine 2002;2(2):165-74.
2002: Hertzel C Gerstein; Kevin E Thorpe; D Wayne Taylor; R Brian Haynes
The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas--a randomized trial.
Diabetes research and clinical practice 2002;55(3):209-19.
2002: Johannes F E Mann; Hertzel C Gerstein; Janice Pogue; Eva Lonn; Salim Yusuf
Cardiovascular risk in patients with early renal insufficiency: implications for the use of ACE inhibitors.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2002;2(3):157-62.
2001: Sonia S Anand; Salim Yusuf; Ruby Jacobs; A D Davis; Qilong Yi; Hertzel C Gerstein; Patty Montague; Eva Lonn
Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP).
Lancet 2001;358(9288):1147-53.
2001: Sarah E Capes; David Hunt; Klas Malmberg; P Pathak; Hertzel C Gerstein
Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview.
Stroke; a journal of cerebral circulation 2001;32(10):2426-32.
2001: Hertzel C Gerstein; Johannes F E Mann; Q Yi; Bernard Zinman; SF Dinneen; Byron J Hoogwerf; J P Hallé; J Young; Andrew Rashkow; C Joyce; S Nawaz; Salim Yusuf
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.
JAMA : the journal of the American Medical Association 2001;286(4):421-6.
2001: Johannes F E Mann; Hertzel C Gerstein; Janice Pogue; J Bosch; Salim Yusuf
Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.
Annals of internal medicine 2001;134(8):629-36.
2001: Hertzel C Gerstein
Diabetes and the HOPE study: implications for macrovascular and microvascular disease.
International journal of clinical practice. Supplement 2001;(117):8-12.
2000: Sonia S Anand; Salim Yusuf; Vladimir Vuksan; Sudarshan Devanesen; Koon K Teo; Patty Montague; Linda E Kelemen; C Yi; Eva Lonn; Hertzel C Gerstein; Robert A Hegele
Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE).
Indian heart journal 2000;52(7 Suppl):S35-43.
2000: Sonia S Anand; Salim Yusuf; Vladimir Vuksan; Sudarshan Devanesen; Koon K Teo; Patty Montague; Linda E Kelemen; C Yi; Eva Lonn; Hertzel C Gerstein; Robert A Hegele; Matthew McQueen
Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)
Lancet 2000;356(9226):279-84.
2000: Hertzel C Gerstein; Johannes F E Mann; Janice Pogue; SF Dinneen; J P Hallé; Byron J Hoogwerf; C Joyce; Andrew Rashkow; J Young; Bernard Zinman; Salim Yusuf
Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators.
Diabetes care 2000;23 Suppl 2():B35-9.
2000: Sarah E Capes; David Hunt; Klas Malmberg; Hertzel C Gerstein
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview.
Lancet 2000;355(9206):773-8.
2000: Sarah E Capes; Hertzel C Gerstein; Abdissa Negassa; Salim Yusuf
Enalapril prevents clinical proteinuria in diabetic patients with low ejection fraction.
Diabetes care 2000;23(3):377-80.
1999: Hertzel C Gerstein
Preventing cardiovascular diseases in people with diabetes.
The Canadian journal of cardiology 1999;15 Suppl G():65G-8G.
1999: Hertzel C Gerstein; S S Reddy; K G Dawson; Jean-François Yale; S Shannon; G Norman
A controlled evaluation of a national continuing medical education programme designed to improve family physicians' implementation of diabetes-specific clinical practice guidelines.
Diabetic medicine : a journal of the British Diabetic Association 1999;16(11):964-9.
1999: Salim Yusuf; Eva Lonn; J Bosch; Hertzel C Gerstein
Summary of randomized trials of angiotensin converting enzyme inhibitors.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1999;21(5-6):835-45.
1999: Hertzel C Gerstein; S Meltzer
Preventive medicine in people at high risk for chronic disease: the value of identifying and treating diabetes.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1999;160(11):1593-5; discussion 1595-6.
1999: Hertzel C Gerstein
Preventive medicine in a diabetes clinic: an opportunity to make a difference.
Lancet 1999;353(9153):606-8.
1999: M Coutinho; Hertzel C Gerstein; Y Wang; Salim Yusuf
The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.
Diabetes care 1999;22(2):233-40.
1998: Sonia S Anand; Salim Yusuf; Vladimir Vuksan; Sudarshan Devanesen; Patty Montague; Linda E Kelemen; Jackie Bosch; Christopher Sigouin; Koon K Teo; Eva Lonn; Hertzel C Gerstein; Robert A Hegele; Matthew McQueen
The Study of Health Assessment and Risk in Ethnic groups (SHARE): rationale and design. The SHARE Investigators.
The Canadian journal of cardiology 1998;14(11):1349-57.
1998: Hertzel C Gerstein
Dysglycaemia: a cardiovascular risk factor.
Diabetes research and clinical practice 1998;40 Suppl():S9-14.
1998: S Meltzer; L Leiter; D Daneman; Hertzel C Gerstein; D Lau; S Ludwig; Jean-François Yale; B Zinman; D Lillie
1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1998;159 Suppl 8():S1-29.
1997: Hertzel C Gerstein
Glucose: a continuous risk factor for cardiovascular disease.
Diabetic medicine : a journal of the British Diabetic Association 1997;14 Suppl 3():S25-31.
1996: Hertzel C Gerstein; J Bosch; Janice Pogue; D W Taylor; B Zinman; Salim Yusuf
Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention Evaluation.
Diabetes care 1996;19(11):1225-8.
1996: Hertzel C Gerstein; J VanderMeulen
The relationship between cow's milk exposure and type 1 diabetes.
Diabetic medicine : a journal of the British Diabetic Association 1996;13(1):23-9.
1995: Hertzel C Gerstein; J R Simpson; S Atkinson; D W Taylor; J VanderMeulen
Feasibility and acceptability of a proposed infant feeding intervention trial for the prevention of type I diabetes.
Diabetes care 1995;18(7):940-2.
1994: Hertzel C Gerstein
Cow's milk exposure and type I diabetes mellitus. A critical overview of the clinical literature.
Diabetes care 1994;17(1):13-9.
1994: Hertzel C Gerstein
Screening for postpartum thyroid dysfunction.
Comprehensive therapy 1994;20(6):331-5.
1993: Hertzel C Gerstein
Incidence of postpartum thyroid dysfunction in patients with type I diabetes mellitus.
Annals of internal medicine 1993;118(6):419-23.
1990: Hertzel C Gerstein
How common is postpartum thyroiditis? A methodologic overview of the literature.
Archives of internal medicine 1990;150(7):1397-400.